Apoptosis of SK-HEP-1 human
hepatoma cells induced by treatment with
ginsenoside Rh2 (G-Rh2) is associated with rapid and selective activation of
cyclin A-associated
cyclin-dependent kinase 2 (Cdk2). Here, we show that in apoptotic cells, the Cdk inhibitory
protein p21(WAF1/CIP1), which is associated with the
cyclin A-Cdk2 complex, undergoes selective proteolytic cleavage. In contrast, another Cdk inhibitory
protein, p27(KIP1), which is associated with
cyclin A-Cdk2 and
cyclin E-Cdk2 complexes, remained unaltered during apoptosis. Ectopic overexpression of p21(WAF1/CIP1) suppressed apoptosis as well as
cyclin A-Cdk2 activity induced by treatment of SK-HEP-1 cells with G-Rh2. The suppressive effects of p21(WAF1/CIP1) were much higher in the cells transfected with p21D112N, an expression vector that encodes a p21(WAF1/CIP1) mutant resistant to
caspase 3 cleavage. Overexpression of
cyclin A in SK-HEP-1 cells dramatically up-regulated
cyclin A-Cdk2 activity and accordingly enhances apoptosis induced by treatment with G-Rh2. These up-regulating effects were blocked by coexpression of a dominant negative allele of cdk2. Furthermore,
olomoucine, a specific inhibitor of Cdks, also blocked G-Rh2-induced apoptosis. These data suggest that the induction of apoptosis in human
hepatoma cells treated with G-Rh2 occurs by a mechanism that involves the activation of
cyclin A-Cdk2 by
caspase 3-mediated cleavage of p21(WAF1/CIP1).